The FDA has approved changes to the labeling of antihemophilic factor/von Willebrand factor complex (human) (Humate-P, CSL Behring) following review of stability data submitted by the manufacturer. The agency determined that

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Subscribe Now!